Insurance

In a landmark move poised to reshape Alzheimer's disease management for millions, China has formally included the innovative treatment Leqembi (lecanemab) in its newly established "Commercial Insurance Innovative Drug List." This strategic decision, announced by BioArctic's partner Eisai,

A Market's Soul on Trial The Lloyd’s of London insurance market, an institution steeped in centuries of tradition and defined by its global influence, is once again facing a profound identity crisis that strikes at the very heart of its corporate character. The decision to reopen an investigation

In an era where digital presence is synonymous with business survival, a deeply concerning paradox has emerged for the United Kingdom's small and medium-sized enterprises, with data revealing that a staggering majority have suffered a cyber incident yet remain critically under-protected. This

The delegated authority broking model that once defined the industry is no longer viable, as the ground has irrevocably shifted beneath it. With delegated business now accounting for approximately 45% of Lloyd's of London's total premium and on a trajectory to become the dominant majority, the

Imagine a stock that’s taken a bruising over the past year, shedding significant value, only to bounce back with a sharp 13% gain in just a month—could this signal a hidden gem for savvy investors, or is it merely a fleeting mirage in a volatile market? F&G Annuities & Life, often referred to as

Imagine a fierce hailstorm tearing through a quiet Oklahoma neighborhood, leaving behind shattered roofs and desperate homeowners who thought their insurance would be a lifeline, only to find their claims denied or drastically underpaid by State Farm, the state’s biggest provider. This isn’t just a